PREVIEW: Danaher Corp (DHR) earnings due 27/Jan at 11:00BST/06:00EDT

Danaher Corp (DHR) Q4 2021 (USD): EPS (exp. 2.54/2.13 GAAP), Revenue (exp. 7.92bln)

REVENUE SEGMENTS:

• Diagnostics: (exp. 2.66bln)
• Environmental And Applied Solutions: (exp. 1.23bln)
• Life Sciences: (exp. 3.95bln)

DIVIDEND:

• Qtrly Dividend: (exp. 0.20)
• FY Dividend: (exp. 0.82)

EPS GUIDANCE:

• Q1 2021 EPS View: (exp. 2.49/2.18 GAAP)
• FY 2021 EPS View: (exp. 9.88/8.43 GAAP)

REVENUE GUIDANCE:

• Q1 2021 Revenue View: (exp. 7.42bln)
• FY 2021 Revenue View: (exp. 29.11bln)
• FY 2022 Revenue View: (exp. 30.94bln)

INDEX WEIGHT:

• 0.5% SPX weight
• Sector/Industry: Health Care/Life Sciences Tools & Services

BROKER RATING:

• Avg Rating: 'Buy'
• Avg Price Target: USD 351.08
• Price Target Changes (last 30 days): 6 upward vs 1 downward